Mammalian Genome

, Volume 5, Issue 8, pp 465–472

Long-term survival of the exon 10 insertional cystic fibrosis mutant mouse is a consequence of low level residual wild-type Cftr gene expression

  • J. R. Dorin
  • B. J. Stevenson
  • S. Fleming
  • E. W. F. W. Alton
  • P. Dickinson
  • D. J. Porteous
Original Contributions

DOI: 10.1007/BF00369314

Cite this article as:
Dorin, J.R., Stevenson, B.J., Fleming, S. et al. Mammalian Genome (1994) 5: 465. doi:10.1007/BF00369314

Abstract

Recently we have created a mouse model of cystic fibrosis (CF) by insertional gene targeting to exon 10. In common with CF subjects, this model displays a low incidence of meconium ileus. This contrasts strikingly with the very high level of fatal intestinal obstruction in the three other CF mouse models so far described. We investigate here the molecular basis of this difference in phenotype. We show that the partial duplication consequent upon insertional gene targeting allows exon skipping and aberrant splicing to produce normal Cftr mRNA, but at levels greatly reduced compared with wild-type mice. Furthermore, instead of the predicted mutant Cftr transcript, a novel mRNA is produced that utilizes cryptic splice sites in the disrupting plasmid sequence. However, we have previously shown that these mice display the ion transport defect characteristic of CF, and mutant animals can be distinguished from their normal littermates on this basis. Consistent with this, residual CFTR function has recently been observed for several “mild” mutations in CF individuals who display pancreatic sufficiency but still develop lung disease. We conclude that (i) residual wild-type mRNA in the exon 10 insertional mutant mouse ameliorates the severity of the intestinal phenotype observed in the absolute “null” CF mice, (ii) the presence of low-level residual wild-type Cftr mRNA does not correct the CF ion transport defect, and (iii) the long-term survival of this insertional mutant mouse provides the opportunity to address the factors important in development of lung disease.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer-Verlag New York Inc. 1994

Authors and Affiliations

  • J. R. Dorin
    • 1
  • B. J. Stevenson
    • 1
  • S. Fleming
    • 2
  • E. W. F. W. Alton
    • 3
  • P. Dickinson
    • 1
  • D. J. Porteous
    • 1
  1. 1.Medical Research Council Human Genetics UnitWestern General HospitalEdinburghUK
  2. 2.Department of PathologyUniversity of Edinburgh Medical SchoolEdinburghUK
  3. 3.Ion Transport LaboratoryNational Heart and Lung InstituteLondonUK

Personalised recommendations